Today: 30 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Omeros shares were trading around $4–$4.60 through early October, then exploded on Oct. 15. Data from the company’s IR site show OMER jumped from $4.10 to $10.42 by Oct 15 closeinvestor.omeros.com. Intraday on Oct 15, it even hit a high around $12.10. This roughly 150% one-day surge was driven by the Novo Nordisk deal. Trading volume was staggering: Benzinga reports ~89.2 million shares traded during the rallybenzinga.com. By mid-October 16 pre-market, OMER was around $9–10 per share – still far above levels seen just days priorts2.techbenzinga.com. The rapid rise snapped years of flat to depressed trading: OMER spent most of 2025 in the $4–5 range until this weekinvestor.omeros.com. The stock’s volatility had been well-known; analysts caution that such biotech names swing wildly on news. As one tech-stock analysis noted, “traders are upbeat” but warned Omeros has “historically tight cash” and high R&D coststs2.tech. In short, Omeros is back in spotlight, but the same factors that make it promising also make it risky.
16 October 2025
···
Menopause Launch Sends Hims & Hers (HIMS) Stock Soaring – What’s Next?

Menopause Launch Sends Hims & Hers (HIMS) Stock Soaring – What’s Next?

Figure: Hims & Hers markets a broad telehealth platform for men’s and women’s healthts2.tech. Its stock has surged with the boom in telehealth and weight-loss treatments. On Oct. 15, Hims & Hers stunned the market by launching a dedicated menopause/perimenopause care program on its “Hers” telehealth platform. The company said the new service would connect women with personalized hormone therapies to ease symptoms like hot flashes and sleep issuests2.tech. This push into a historically underserved sector met eager investor demand. As Benzinga and TS2.tech reported, HIMS stock raced +10–13% that day, trading near $60 with extremely heavy volumets2.tech. By the close, HIMS was up roughly +16%, a one-day gain not seen in monthsts2.techts2.tech.
16 October 2025
··
RYOJ Stock Rockets 180% Overnight – What’s Fueling the Surge?

RYOJ Stock Rockets 180% Overnight – What’s Fueling the Surge?

Shares of rYojbaba have been on a roller-coaster since its Nasdaq debut. After peaking at $3.75 on debut day, RYOJ plunged to an intraday low of $1.81 on Sept 4tradingview.com. SimplyWallSt flagged sentiment “deteriorates” when the stock fell 19% on Sept 4 and another 16% on Oct 3simplywall.st. Last week’s rally flipped the script: trading volume spiked as investors piled in, pushing the pre-rally price up by ~2.5% for the weektradingview.com. The blockbuster Oct 15 move appears to have been driven by heavy trading and momentum rather than any company announcement. For perspective, tech-heavy indexes have also been volatile: the Nasdaq Composite hit new records early October before pulling back on trade-war and Fed concernsts2.techts2.tech. rYojbaba is a small-cap Japanese firm founded in 2015 and based in Fukuokatradingview.com. The company’s two business segments are Labor Consulting Services and Health Servicesreuters.com. Its CEO is Ryoji Baba, and it was co-founded by Masataka Sakai in Jan 2015tradingview.com. Per its IPO filings, proceeds will go toward scaling an IT consulting platform, hiring staff, and expanding overseas as well as opening/acquiring more clinicsglobenewswire.com. With about 28 clinics and 2 salons already in Japanglobenewswire.com, rYojbaba aims to grow by franchising and M&A. The business is
16 October 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 16.10.2025

ENDEDLive coverage has endedEnded: October 18, 2025, 6:00 AM EDT Centerspace (CSR) Crosses Above 200-Day Moving Average, Signals Bullish Momentum October 16, 2025, 11:07 PM EDT. Centerspace (CSR) shares climbed to as high as $61.16 Thursday, rising above the 200-day moving average of $60.64. The move comes as CSR trades about +1.5% on the session, with a last trade near $60.75. The breakout above the 200 DMA suggests a potential shift in near-term momentum. Over the past year, CSR has traded between a low of $52.76 and a high of $75.92, framing the current price within the 52-week range. The
16 October 2025
··
SHOCKING: Asteroid Discovered Just Days Ago Will Buzz Earth TODAY (Closer Than the Moon) – What Experts and Investors Are Saying

SHOCKING: Asteroid Discovered Just Days Ago Will Buzz Earth TODAY (Closer Than the Moon) – What Experts and Investors Are Saying

Astronomers have identified Asteroid 2025 TP5 as a very close but safe Earth flyby. According to NASA’s Jet Propulsion Lab data, 2025 TP5 will swoop by at 4:09 p.m. EDT on Oct. 15, 2025, at ~60,328 miles from Earth’s centerspace.com. By comparison, the Moon orbits ~238,855 miles away. After the Earth flyby, JPL reports that 2025 TP5 will come as close as 74,616 miles to the Moon on Oct. 16space.com. At an estimated 54 ft diameterspace.com, it is a medium-sized near-Earth asteroid. Notably, 2025 TP5 was undetected until Oct. 13, just two days before its passspace.com, showing how last-minute such discoveries can be. The close approach is historic in how near it is – Space.com calls it “closer to Earth than the moon”space.com. Yet scientists emphasize no danger. The Asteroid Terrestrial-impact Last Alert System in Hawaii discovered TP5 and confirmed it “was not a threat”space.com. In fact, only much larger bodies crossing very near Earth trigger a “potentially hazardous” warningabcnews.go.com. By that standard, 2025 TP5 is about ten times smaller and will stay well outside any impact zone. Astronomers note that sub-25m asteroids typically burn up harmlessly if they enter the atmospherediscovermagazine.com, perhaps as bright fireballs.
16 October 2025
····
Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon Stock Shock: MacKenzie Scott Sells $12.6 Billion Stake — What’s Next?

Billionaire philanthropist MacKenzie Scott has significantly cut her Amazon.com holdings. A Bloomberg report on Oct. 14 noted that Scott reduced her stake by 42% over the past year, citing a new SEC filingbloomberg.com. The filing shows Scott now owns about 81.1 million Amazon shares, down roughly 58 million from a year earlier. At Amazon’s market price, that divestment is worth about $12.6 billionbloomberg.comtipranks.com. It isn’t clear whether those shares were sold on the open market or donated to charity – Scott’s filings simply report the lower share counttimesofindia.indiatimes.com. Amazon itself did not comment on the filing. Under her divorce terms Scott’s shares are reported by Bezos, which is why the SEC filing lists her stake under his namebloomberg.comtipranks.com. Notably, Bezos still holds well over 960 million shares after his own recent sell-offstipranks.com. After news of the filing, Amazon’s stock dipped modestly – closing around $216.39 on Oct. 15, about 2% below the prior day’s closetipranks.com. Traders noted this was likely just a short-term reaction, as the sale reflects Scott’s portfolio choices rather than any change in Amazon’s fundamentals.
16 October 2025
·
TSMC Stock Skyrockets on AI Boom — Analysts See More Upside

TSMC Stock Skyrockets on AI Boom — Analysts See More Upside

TSMC’s latest results have been outstanding. In Q2 2025, the company reported revenue of US$30.1 billion, a 44% jump year-over-yearts2.tech, with net profit of roughly T$398.3 billion. Demand for TSMC’s most advanced nodes is exceptionally strong: cutting-edge chips now account for about 60% of revenuets2.techts2.tech, and high-performance computing/AI wafers made up roughly 60% of Q2 sales. TSMC’s pricing power and scale have kept margins very high, underpinning its profit growth. Looking ahead, Q3 is expected to be even stronger. On Oct 9, TSMC announced preliminary Q3 sales of NT$989.9 billion, up ~30% from a year agots2.tech – well above the consensus estimate. Analysts now forecast the quarter’s net profit around T$452 billion, the largest in TSMC historyreuters.com. In response, on Oct 16 the company raised its 2025 revenue growth guidance to the mid-30% rangereuters.com. Management emphasized that “AI demand actually continues to be very strong – more strong than we thought three months ago”reuters.com, and said signals from customers’ customers have only “strengthening” their conviction in the AI-driven growth cyclereuters.com. These trends suggest TSMC’s full-year sales could comfortably exceed $100 billion.
16 October 2025
···
Bull Run or Bubble? Investors Eye New Highs as EUR/USD Rallies and Fed Prepares Cuts

Bull Run or Bubble? Investors Eye New Highs as EUR/USD Rallies and Fed Prepares Cuts

Global markets were buoyed this week by better-than-feared news on several fronts. After a rough September, U.S. bank earnings beat estimates: Morgan Stanley and Bank of America both delivered upside surprises, which helped calm trade-war jittersreuters.com. European stocks likewise rallied, led by luxury companies: LVMH reported positive third-quarter sales and its shares surged as much as 14%, the biggest one-day rise since 2001reuters.comreuters.com. European indices closed higher by ~0.6%reuters.com. As Stefan Bauknecht of DWS observes, the luxury data “surprised investors positively and are likely to keep the sector’s share price momentum alive”reuters.com. In Asia, stock markets largely echoed the U.S. rally. Japan’s Nikkei climbed ~1.8%, lifted by gains in chip- and AI-related names after strong results from U.S. tech peers, including TSMCreuters.com. South Korea’s Kospi jumped ~2.2% to a record high on optimism over a potential U.S.-Korea trade dealreuters.com. Australia’s ASX 200 also reached record levels on expectations of looser policy after weaker jobs data. Emerging markets ex-Asia gained ~1.9%reuters.com. Still, China’s markets were quiet or slightly down, reflecting continued uncertainty over trade and rare-earth export curbs. “I remain of the belief that…markets are headed higher,” said Michael Brown, a senior strategist, noting that current volatility is likely noise rather
16 October 2025
···
MercadoLibre (MELI) Stock Dips Amid Brazil Competition – Analysts Eye Long-Term Upside

MercadoLibre (MELI) Stock Dips Amid Brazil Competition – Analysts Eye Long-Term Upside

MercadoLibre’s stock opened near $2,181.92 on Oct. 15 but fell sharply into the afternoon. Reuters data show a midday price around $2,048.35 – about 5.1% lower than the previous closereuters.com. This continues a pullback from late-September highs when the stock briefly approached its 52-week peak. Trading volume has been elevated amid market jitters about Latin American growth. In October so far, MELI is down roughly 10–15% from its September peakstockanalysis.comreuters.com. Most of the recent price swings reflect broader volatility in tech and e-commerce stocks, especially in emerging markets. Notably, on Oct. 9 the company announced its Brazil pharma move, but the stock reaction was muted. Instead, analysts attribute the slide to concerns over competitive pressures and currency issues. For example, JPMorgan cited intensified Brazilian competition as a drag on marginsfinviz.com. Overall, MercadoLibre remains up modestly year-to-date, but below the highs of late 2024.
16 October 2025
··
Pinnacle Food Group (PFAI) Stock Explodes 140% on Trade News – What’s Behind the Rally?

Pinnacle Food Group (PFAI) Stock Explodes 140% on Trade News – What’s Behind the Rally?

Key Facts: Pinnacle Food Group shares closed at about $4.57 on Oct 15, 2025, up roughly 139% from the prior day’s $1.87 closereuters.comstockanalysis.com. This extreme one‐day surge followed U.S. political headlines: President Trump signaled tighter tariffs on Chinese cooking-oil imports, sparking a rally in agri-related stocksfastcompany.combenzinga.com. Pinnacle – a small Vancouver‐based smart farming/hydroponics firm – had no new press release in early October, so today’s move appears driven by the broader ag sector boom. and a $286K profit in Julyglobenewswire.com; CEO Jiulong You said at that time they planned to expand sales in Asia and shift into larger systemsglobenewswire.com.) Other agriculture-linked stocks jumped similarly – e.g. Sadot Group leapt ~80% and soybean giants like Bunge and ADM also spikedbenzinga.commarketscreener.com. No official announcement by Pinnacle explains the surge, and market observers call the move highly speculative. Pinnacle Food Group has been a thinly-traded small-cap. Through early Oct. 2025 its stock floated around $1.80–$1.95. On Tuesday Oct 14 it closed near $1.87reuters.com. On Oct 15, the stock opened sharply higher and ultimately closed at $4.57, up about $2.66 on the daystockanalysis.com. Average volume exploded: Reuters reported 6.6 million shares traded by mid‐dayreuters.com, versus a 3-month average under 100,000. Late Oct. 15 after-hours
16 October 2025
·
Mawson Infrastructure (MIGI) Stock Skyrockets on Crypto Rally and Executive Shakeup

Mawson Infrastructure (MIGI) Stock Skyrockets on Crypto Rally and Executive Shakeup

Key Facts: As of Oct. 15, 2025, Mawson Infrastructure shares are trading around $1.00–1.30, roughly double where they stood a week earlier Financialcontent Marketscreener. The stock jumped +13.36% on Oct. 14 Financialcontent, and has surged nearly 140% over the past two weeks Stockinvest. Drivers include a volatile crypto market and mixed company news. In recent months Mawson signed a 64 MW colocation deal with ASIC maker Canaan Inc. to host 17,453 mining rigs Mawsoninc, but also grappled with management turmoil. CEO Rahul Mewawalla was abruptly fired “for cause” amid a fraud lawsuit in July Ainvest, raising governance concerns. Nasdaq granted Mawson extra time to meet listing requirements Mawsoninc. Analysts remain cautious: H.C. Wainwright maintains a Neutral rating while the stock recovers Investing. On Oct. 15 MIGI continued its recent rebound, trading around $1.28 by mid‐morning Marketscreener. Yesterday the stock closed at $1.00, a 13.36% one-day gain Financialcontent. This follows a volatile week: MIGI first doubled in price in early October amid a crypto market rally, then slid back after Friday’s crypto sell-off and company news, before rebounding Monday and Tuesday. Traders cited two big influences. First, Bitcoin and crypto markets: Bitcoin hit new all-time highs above $126,000 on Oct. 6
16 October 2025
···
First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

According to market reports, FHN shares traded around $20 on Oct 15, 2025 after the selloffbloomberg.com. This was down ~13% from Wednesday’s open near $23.02marketbeat.com. The share price briefly touched an intraday low of $19.99bloomberg.com. For perspective, that is the steepest one-day drop since regulators derailed TD Bank’s planned $13.4 billion merger with FHN in May 2023bloomberg.com. FHN’s 50-day and 200-day moving averages were near $22.5 and $20.7 respectivelymarketbeat.com, so the plunge pushed the stock back towards longer-term support levels. Overall, FHN has been up modestly on the year, but this October slide wiped out recent gains. First Horizon reported strong Q3 results on Oct 15, beating Wall Street expectationsinvesting.com. Adjusted earnings were $0.51 per share on $889 million of revenueinvesting.com. Net interest income grew by ~$33 million and net interest margin expanded to about 3.55%investing.com, thanks to higher loan yields and gradual deposit repricing.
16 October 2025
··
Microvast Stock Skyrockets 19% on $125M Equity Raise & Battery Breakthroughs

Microvast Stock Skyrockets 19% on $125M Equity Raise & Battery Breakthroughs

Microvast shares surged ~19% on Oct 15, closing at $6.26stockanalysis.com. That jump followed a breakout from a recent trading range: MVST was around $4.33 on Oct 10, climbed to ~$5.25 on Oct 14, and then rocketed on Oct 15stockanalysis.com. In early trading the stock hit as high as $6.41 intraday. This rally came on heavy volume – about 19.5 million shares – signaling strong buying interest. By comparison, institutional volume and interest have been building: Miacis, for example, noted MVST trades far above its 50-day and 200-day moving averagesmarketbeat.com, reflecting the stock’s recent momentum. The market capitalization is now roughly $1.7 billionmarketbeat.com, and MVST has a high beta, underscoring its volatility. Two big developments drove today’s move. First, on Oct 3 Microvast announced a $125 million follow-on equity offering to fund growthtipranks.com. According to TipRanks, this controlled offering allows Microvast to issue new shares up to $125M for “general corporate purposes” like debt refinancing, acquisitions, capex, and working capitaltipranks.com. The fresh capital is intended to accelerate plant expansions and R&D, especially for next‑generation batteries. As one analysis noted, MVST “surged 21.25% after a $125M equity raise to scale production and develop all-solid-state batteries”ainvest.com. Investors rewarded the news in part because
15 October 2025
·
Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics has been in the news for its upcoming conference presentations and strong trial data. On October 13, 2025 the company announced that expanded data from the VIRAGE Phase 2b trial will be presented at the ESMO 2025 Congress on October 20sec.gov. In VIRAGE, the oncolytic adenovirus VCN-01 is given with gemcitabine/nab‑paclitaxel standard chemotherapy. Interim abstract data show that VCN-01 + chemotherapy substantially improved overall survival and progression-free survival versus chemotherapy alonesec.govsec.gov. Patients receiving VCN-01 saw median OS up to ~11–14 months versus ~8–11 months on chemo alonesec.govsec.gov. Notably, patients given two doses of VCN-01 before the 4th chemo cycle showed a 14.8 vs. 11.6 month OS improvementsec.gov. The study met its primary endpoints, with VCN-01 being well tolerated. Simultaneously, Theriva announced a poster at IDWeek 2025 featuring interim safety and pharmacokinetic data from its ongoing Phase 1b/2a trial of SYN-004 in allogeneic bone marrow transplant recipientssec.gov. Ribaxamase is an oral enzyme designed to protect the gut microbiome during IV antibiotic use and prevent graft-versus-host disease. The IDWeek poster will cover safety/tolerability in this context.
15 October 2025
Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

In mid-October Vivakor’s stock surged amid fresh corporate deals. On Oct. 15 the company revealed it had signed a non-binding term sheet for a $40M commodity intermediation facilityglobenewswire.com. This arrangement is intended to underwrite letters of credit, bonds or cash deposits to support Vivakor Supply & Trading, LLC’s physical crude oil purchasesglobenewswire.com. CEO James Ballengee said the deal “highlights our growth initiative for Vivakor’s trading segment,” enabling them to integrate more oil volumes across their trucks and facilities and “driv[e] immediate accretive revenue while diversifying and expanding our crude oil marketing operations”globenewswire.com. The facility would have a one-year term and up to $40M in available credit supportglobenewswire.com. This announcement built on other recent funding news. On Sept. 29 Vivakor signed a term sheet to issue $25M of new convertible preferred stock in exchange for up to $23M in fundingglobenewswire.com. Under that deal, about $15M of proceeds will seed a dedicated trading credit line for Vivakor’s oil marketing division, $3M will bolster general working capital, and at least $5M of oil and equipment will go to its remediation segmentglobenewswire.com. Ballengee explained the package “would directly support two of our expanding business segments, crude oil marketing and remediation,” creating synergies across Vivakor’s
15 October 2025
··
Sea Limited (SE) Stock Tumbles Nearly 10% as Analysts Debate Shopee’s Growth vs. High Valuation

Sea Limited (SE) Stock Tumbles Nearly 10% as Analysts Debate Shopee’s Growth vs. High Valuation

After a strong 2025 rally, Sea’s stock has been volatile this week. The shares opened Oct. 15 near $184 but slumped to a day’s low of about $162, settling at $163.42reuters.com. This ~10% one-day drop wiped out weeks of gains, in line with a broader tech selloff. Trading volume on Oct. 15 far exceeded recent averagesreuters.com. Over the past 52 weeks, SE stock traded between $92.50 and $199.30reuters.com, so even after this pullback the shares remain well above early-year lows. Market watchers point out the stock’s valuation is now stretched – at ~94x trailing EPSreuters.com – so even modest profit expectations are fully baked in. As of Oct. 15, institutional ownership was about 59.5%marketbeat.com, implying a lot of buy-side interest. Technical levels are notable: the stock briefly pierced its 52-week high in early Oct before easing. Many traders will watch if $160 holds as near-term support, while analysts debate if the pullback is a buying opportunity.
15 October 2025
··
United Airlines Stock Soars on Strong Q3 Results, Bullish Q4 Outlook

United Airlines Stock Soars on Strong Q3 Results, Bullish Q4 Outlook

United’s stock has climbed steadily into the third-quarter earnings release. On Monday, Oct. 13, UAL closed at $99.25, up 2.7% on the daydaytraders.com, and above the week’s open. By Tuesday it traded around $103–$104 per share, and it closed Oct. 15 near $104.18investing.com. This marks roughly a 5% gain in two days and a roughly 13% gain over the last three monthsinvesting.com. The advance came as peers rallied: notably, Delta’s Oct. 9 earnings beat sent airline stocks higherbenzinga.com. Market bulls cite United’s positioning in premium and global travel; bears note airlines’ general volatility and high debt. Still, UAL’s recent surge reflects optimism that demand remains strong heading into year-end. United’s Q3 earnings were broadly better than analysts expected. Reported on Oct. 15 after markets closed, UAL posted adjusted EPS of $2.78 and revenue $15.2 billion, up 2.6% year-over-yearinvesting.com. Pre-tax profit was $1.3 billiontipranks.com. Revenue gains were broad-based: premium cabin sales rose ~6% YoY, frequent-flyer revenue +9%, while Basic Economy and cargo also grewprnewswire.cominvesting.com. CEO Scott Kirby noted that investments in cabins, in-flight Wi-Fi, and service have built “brand-loyal customers” who help United be resilient through economic swingsinvesting.comreuters.com.
15 October 2025
··
Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

Hims & Hers Stock Soars on New Menopause Care Expansion – What Comes Next?

Hims & Hers’ women’s health platform now offers specialized menopause and perimenopause careinvestors.hims.com. The new service is aimed at improving access to hormone therapies for symptoms like hot flashes and sleep issues, expanding a platform that already serves over 500,000 women. The October 15 jump in HIMS stock was driven by the menopause announcement. Investors saw the new specialty as a major driver of future growth, helping Hims & Hers address a long-ignored need in women’s health. As Benzinga reported, the stock closed the day up about 10–13% after the newsbenzinga.com. This contrasts with modest moves earlier in the week, indicating strong investor appetite for the expansion. Volume spiked – roughly fifteen times the stock’s average daily volume – underscoring the market’s excitementbenzinga.com.
15 October 2025
·
Sana Biotech Shares Skyrocket on 100x Hype – What’s Behind the Rally?

Sana Biotech Shares Skyrocket on 100x Hype – What’s Behind the Rally?

On Oct. 15, SANA spiked as investors reacted to hedge fund manager Eric Jackson’s bullish call. In a post on X, Jackson proclaimed: “Biotech is back. Rates are falling, inflation is cooling, and money is rotating from megacaps to growth again,” and suggested “$SANA looks like the next 100-Bagger platform”benzinga.com. Benzinga and other outlets noted that this endorsement sent SANA shares up sharply that morningbenzinga.com. Earlier in the week, SANA’s stock had been quietly rallying on general biotech enthusiasm and anticipation of data. Over the past five trading days the stock closed at $4.45, $4.32, $4.34, $4.45 and $5.62investing.com, a roughly 26% gain in two sessions. Market data show a highly volatile week: at one point Oct. 15 the intraday high hit $6.55investing.com. MarketBeat reported the share jump as a 47.2% move on Oct. 15marketbeat.com, though the actual close represented about +26% from the prior day.
15 October 2025
··
1 … 271 272 273 274 275 … 397

Stock Market Today

  • S&P 500 futures advance as rate hike risks and trade deficit weigh
    June 30, 2026, 5:06 AM EDT. U.S. stock futures were higher Tuesday, with E-mini S&P 500 up 0.7% and Nasdaq 100 futures advancing more than 1%, trading as 10-year Treasury yields held near 4.38%. High yields kept pressure on borrowing with the Fed still seen as hawkish and rate hike bets intact. The U.S. goods trade deficit widened to $105.8 billion, pointing to more imports over exports, with some pressure on manufacturing and exporters. Traders looked for defensive names as sector risks lingered. AST SpaceMobile jumped 21.44% after satellite news, Cerebras Systems was up 19.04% following positive analyst calls, and Astera Labs gained 16.39% after UBS lifted its price target. On the downside, Honeywell fell more than 50% after a reverse stock split. NIKE and Constellation Brands' earnings are also on the agenda as investors watch for signs on consumer demand and costs.
Go toTop